Boston Scientific (BSX) Q2 Earnings: What Awaits The Stock?
Zacks Investment Research | Jul 20, 2017 09:16PM ET
Boston Scientific Corporation (NYSE:BSX) is scheduled to report second-quarter 2017 results before the opening bell on Jul 27. Last quarter, the company’s earnings missed the Zacks Consensus Estimate by 3.3%. However, it posted an average beat of 0.03% in the trailing four quarters. Let’s see how things are shaping up prior to this announcement.
Factors at Play
Ahead of Boston Scientific’s earnings release, we believe, the quarter’s performance will be grossly impacted by the company’s product recall issue within Europe. Notably, earlier this year, the news surfaced that Boston Scientific is recalling one of its prime products, the Lotus range of heart devices from Europe because of device malfunctions.
Abbott Laboratories (NYSE:ABT) Price and EPS Surprise
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.